Publications by authors named "Terry Melim"

Claim this Profile
F
Fibronectin extra domain A as a drug delivery targeting epitope for rheumatoid arthritis.
Victor Z Sun, Terry L Melim, Soumya Mitra, Jamie E Erickson, Shaughn H Bryant

Adv Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids.
Sarah S Wilson, Martha Mayo, Terry Melim, Heather Knight, Lori Patnaude

Front Immunol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrugs for colon-restricted delivery: Design, synthesis, and in vivo evaluation of colony stimulating factor 1 receptor (CSF1R) inhibitors.
Dawn M George, Raymond J Huntley, Kevin Cusack, David B Duignan, Michael Hoemann, Terry Melim

PLoS One· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study.
Catherine S Tripp, Carolyn Cuff, Andrew L Campbell, Barbara A Hendrickson, Jeff Voss, Terry Melim

Adv Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rodent models of aging bone: an update.
Farhan A Syed, Terry Melim

Curr Osteoporos Rep· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, synthesis, and biological evaluation of indomethacin derivatives as cyclooxygenase-2 inhibiting nitric oxide donors.
Shiow-Jyi Wey, Michael E Augustyniak, Edward D Cochran, James L Ellis, Xinqin Fang, Terry L Melim

J Med Chem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor.
James L Ellis, Michael E Augustyniak, Edward D Cochran, Richard A Earl, David S Garvey, Terry L Melim

Inflammopharmacology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods.
Delano V Young, Edward D Cochran, Vijay Dhawan, Richard A Earl, James L Ellis, Terry L Melim

Biochem Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis